NCMM Group Leader Dr Emma Haapaniemi will collaborate with centre leaders and NCMM Associate Investigators Prof Johanna Olweus and Prof Karl-Johan Malmberg as part of the new centre, Precision Immunotherapy Alliance (PRIMA).
Molecular discoveries have the potential to lead to advancements in the understanding and treatment of disease. Over 90 scientists visited Oslo to discuss the latest dynamic kinetochore research
Dr Tatiana Belova (NCMM), Dr Salim Ghannoum (Oslo University Hospital) and Saikat Das Sajib (University of Tromsø) have been awarded the funding by the national network for breast cancer research
Anita Kavlie, national coordinator for EATRIS Norway, pitched the benefits of the EATRIS research infrastructure to a full house at innovation hangouts – a new meeting place for academia and industry organised by the Life Science Growth House
The origin of life on Earth is one of humankind’s greatest open questions. Researchers at NCMM wanted to investigate how the transition from non-living to living matter on the early-Earth took place by studying how molecules like DNA and RNA are exchanged between primitive cells
On the 13th & 14th of June NCMM held its first scientific retreat in three years. The retreat comprised of two days of excellent talks from the research environment and Associate Investigator network representing NCMM’s wide expertise in molecular medicine
Where are they now? Meet NCMM alumna Rønnaug Steen Kolve and learn about her career path from studies in molecular medicine to managing first a core facility at an international research center and then research funding actions at the Norwegian Cancer Society.
Dr Liye He is a Postdoctoral Researcher with a background in computational science and precision medicine in the group of Professor Tero Aittokallio at FIMM. He recently spent time with the Mathelier group at NCMM
Elham Shojaeinia is a PhD student in the Esguerra group at NCMM. She recently visited DANDRITE at Aarhus University, Denmark to learn in depth about the principles of neural organization
NCMM group leader, Dr Marieke Kuijjer and Dr Xavier Tekpli (Oslo University Hospital) have been awarded the funding by the foundation for the promotion of cancer research (UNIFOR-FRIMED)
Abnormal epigenetic changes are observed in the development of multiple types of cancer. Researchers at NCMM wanted to explore the molecular mechanisms driving these processes
The NorMIC series of workshops has established itself as an important platform for Norway and Scandinavia-based biomedical researchers to gain scientific knowledge of optical microscopy
An online version of the NCMM Annual Report 2021 is now available
The Nordic EMBL Partnership Coordination and Operations team assembled in Oslo for two days to advance joint initiatives.
Are you impressed when NASA manages to calculate the time and speed of a rocket’s trajectory? A new study shows that your brain has a “nerd centre” capable of even more complex calculations.
Ieva Rauluševičiūtė is a Doctoral Research Fellow in the Mathelier group at NCMM. She recently spent one month with the groups of Dr Judith Zaugg and Dr Arnaud Krebs at the EMBL Headquarters in Heidelberg, Germany.
NCMM is delighted to announce that Dr Charlotte Boccara has been recruited as a new group leader under the Centre’s precision medicine umbrella. Dr Boccara will join us in April 2022 . She will establish and head the Systems Neuroscience & Sleep group at NCMM, aiming to decode sleep function in healthy development.
In this article, we meet NCMM Group Leader and Zebrafish Core Facility Leader, Camila Esguerra, and learn about the power of zebrafish as a model organism and the core facility she directs at the University of Oslo.
NCMM is delighted to announce that Dr Biswajyoti Sahu has been recruited as a new group leader for Precision Medicine. Dr Sahu will join us in September 2022 from the University of Helsinki, Finland.
NCMM Group Leader Sebastian Waszak and his team are advancing the understanding of childhood brain tumor evolution, exploring new approaches to molecular diagnostics, and utilizing knowledge gained from clinical cancer genomics.
Anne Martina Kraus and Sophie Mottl are combining their clinical training with computational methods to understand the genetics of childhood brain tumors
NCMM group leader Dr Emma Haapaniemi, Professor Eivind Valen and collaborators will advance gene therapy for primary immunodeficiencies
The Norwegian research environment stands to benefit from the launch of the new European Molecular Biology Laboratory programme ‘Molecules to Ecosystems’
Joint seed funding from NCMM and UiT has been awarded to four projects investigating lung cancer treatment, pathogenic bacterial cells, breast cancer metastasis and kidney inflammation progression.
Torfinn is starting on the 1st of February 2022 and will be joining NCMM’s IT team. He will be working with NCMM’s computer servers.